Nancy Klimas
Nancy Klimas
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Mycobacterium Infections, Nontuberculous, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, bacterial infectious disease, gram-positive bacterial infections, long COVID-19, lung disorder, mycobacterial infectious disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-09-29 | NCT07021794 |